Maximilian Kordes

836 total citations
17 papers, 417 citations indexed

About

Maximilian Kordes is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Maximilian Kordes has authored 17 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 5 papers in Cancer Research. Recurrent topics in Maximilian Kordes's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (5 papers) and Pancreatitis Pathology and Treatment (5 papers). Maximilian Kordes is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (5 papers) and Pancreatitis Pathology and Treatment (5 papers). Maximilian Kordes collaborates with scholars based in Sweden, Germany and Italy. Maximilian Kordes's co-authors include Kai Matuschewski, Matthias Löhr, Julius Clemence R. Hafalla, Lars Larsson, Lars Engstrand, Steffen Borrmann, Olivier Silvie, Rainer Christoph Miksch, Jingru Yu and Stina Lindblad and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Maximilian Kordes

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximilian Kordes Sweden 10 161 158 121 75 70 17 417
Ya‐Wen Cheng Taiwan 14 187 1.2× 110 0.7× 41 0.3× 66 0.9× 97 1.4× 19 479
Yosuke Baba Japan 13 132 0.8× 123 0.8× 20 0.2× 111 1.5× 139 2.0× 26 419
Yi Mao China 9 134 0.8× 47 0.3× 24 0.2× 109 1.5× 40 0.6× 19 448
Han Xian Aw Yeang United States 9 136 0.8× 45 0.3× 114 0.9× 163 2.2× 12 0.2× 13 417
Douglas Richesson United States 12 149 0.9× 165 1.0× 123 1.0× 92 1.2× 97 1.4× 15 796
Van Huynh United States 10 89 0.6× 75 0.5× 89 0.7× 41 0.5× 16 0.2× 28 279
A Tschuschner Germany 9 90 0.6× 56 0.4× 13 0.1× 44 0.6× 62 0.9× 16 421
Dale J. Calleja Australia 7 285 1.8× 72 0.5× 43 0.4× 351 4.7× 46 0.7× 9 553

Countries citing papers authored by Maximilian Kordes

Since Specialization
Citations

This map shows the geographic impact of Maximilian Kordes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Kordes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Kordes more than expected).

Fields of papers citing papers by Maximilian Kordes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian Kordes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Kordes. The network helps show where Maximilian Kordes may publish in the future.

Co-authorship network of co-authors of Maximilian Kordes

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Kordes. A scholar is included among the top collaborators of Maximilian Kordes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Kordes. Maximilian Kordes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wilmink, Hanneke, T. Macarulla Mercadé, Chris Verslype, et al.. (2025). 262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study. Annals of Oncology. 36. S103–S103. 1 indexed citations
2.
Linder, Stefan, Maximilian Kordes, Maria Liljefors, et al.. (2022). Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia – A comparison with pancreatic ductal adenocarcinoma. Pancreatology. 22(5). 598–607. 7 indexed citations
3.
Kordes, Maximilian, Lars Larsson, Lars Engstrand, & Matthias Löhr. (2021). Pancreatic cancer cachexia: three dimensions of a complex syndrome. British Journal of Cancer. 124(10). 1623–1636. 46 indexed citations
4.
Yu, Jingru, Alexander Ploner, Maximilian Kordes, et al.. (2021). Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma. International Journal of Cancer. 148(8). 2048–2058. 16 indexed citations
5.
Vujasinović, Miroslav, Patrick Maisonneuve, Rasmus Berggren, et al.. (2021). Risk of developing pancreatic cancer in patients with chronic pancreatitis. Pancreatology. 21. S38–S38. 1 indexed citations
6.
Kordes, Maximilian, et al.. (2021). TLR9 signalling inhibits Plasmodium liver infection by macrophage activation. European Journal of Immunology. 52(2). 270–284. 7 indexed citations
7.
Hagey, Daniel W., Maximilian Kordes, André Görgens, et al.. (2021). Extracellular vesicles are the primary source of blood‐borne tumour‐derived mutant KRAS DNA early in pancreatic cancer. Journal of Extracellular Vesicles. 10(12). e12142–e12142. 34 indexed citations
8.
Vujasinović, Miroslav, Patrick Maisonneuve, Nikola Panić, et al.. (2020). Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis. Journal of Clinical Medicine. 9(11). 3720–3720. 42 indexed citations
9.
Kordes, Maximilian, et al.. (2020). Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers. 12(11). 3234–3234. 34 indexed citations
10.
Kordes, Maximilian, et al.. (2019). Survival Benefits of Chemotherapy for Patients with Advanced Pancreatic Cancer in A Clinical Real-World Cohort. Cancers. 11(9). 1326–1326. 21 indexed citations
11.
Kordes, Maximilian & Marco Gerling. (2019). Variations in the management of diarrhoea induced by cancer therapy: results from an international, cross-sectional survey among European oncologists. ESMO Open. 4(6). e000607–e000607. 7 indexed citations
12.
Löhr, Matthias, Maximilian Kordes, Wiktor Rutkowski, et al.. (2018). Overcoming diagnostic issues in precision treatment of pancreatic cancer. Expert Review of Precision Medicine and Drug Development. 3(3). 189–195. 1 indexed citations
13.
Loehr, Matthias, Maximilian Kordes, Jan‐Erik Frödin, et al.. (2018). Applying evidence-based software for NGS in pancreatic cancer: First results from the PePaCaKa study.. Journal of Clinical Oncology. 36(15_suppl). e16214–e16214. 1 indexed citations
14.
Kordes, Maximilian, Michael Röring, Christoph Heining, et al.. (2015). Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling. Leukemia. 30(4). 937–946. 34 indexed citations
15.
Kordes, Maximilian, Kai Matuschewski, & Julius Clemence R. Hafalla. (2011). Caspase-1 Activation of Interleukin-1β (IL-1β) and IL-18 Is Dispensable for Induction of Experimental Cerebral Malaria. Infection and Immunity. 79(9). 3633–3641. 59 indexed citations
16.
Baumeister, Stefan, Jochen Wiesner, Armin Reichenberg, et al.. (2011). Fosmidomycin Uptake into Plasmodium and Babesia-Infected Erythrocytes Is Facilitated by Parasite-Induced New Permeability Pathways. PLoS ONE. 6(5). e19334–e19334. 57 indexed citations
17.
Silvie, Olivier, et al.. (2009). Vaccine‐Like Immunity against Malaria by Repeated Causal‐Prophylactic Treatment of Liver‐StagePlasmodiumParasites. The Journal of Infectious Diseases. 199(6). 899–903. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026